Investors
2023 Second quarter announcement
We announced our second quarter 2023 results on Wednesday 26 July. Access our Q2 2023 results and latest Annual Report below.
We’re confident in our future
Our bold ambitions for patients are reflected in our commitments to a step-change in growth and performance over the period to 2026. This means more GSK vaccines and medicines, including innovative new products, will reach more people than ever before.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Innovation stories
Biopharma experts believe a ‘greater exchange of skills and technology’ will deliver the best results for patients
Back to school immunity: vaccination catch-ups are needed to stop the escalation of preventable diseases in children
New digital assessment tool could improve the lives of people living with HIV by helping healthcare professionals uncover hidden burdens
‘300 million people with chronic hepatitis B are waiting to re-start their lives. This is my story of hope.’
Scientists gain ground in centuries-long malaria struggle – but more innovation is needed to stay ahead of evolving parasites
Modern technologies are doubling the odds of scientists making life-changing medical discoveries
Remission could be possible for people with severe asthma, giving them a new outlook on life
Vaccinations are not just for children: why adult immunisation is a health and economic necessity
‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics
‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women
